» Articles » PMID: 38673797

Glucosamine Enhancement of Learning and Memory Functions by Promoting Fibroblast Growth Factor 21 Production

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Apr 27
PMID 38673797
Authors
Affiliations
Soon will be listed here.
Abstract

Fibroblast growth factor 21 (FGF21) plays a crucial role in metabolism and brain function. Glucosamine (GLN) has been recognized for its diverse beneficial effects. This study aimed to elucidate the modulation of FGF21 production by GLN and its impact on learning and memory functions. Using both in vivo and in vitro models, we investigated the effects of GLN on mice fed with a normal diet or high-fat diet and on mouse HT22 hippocampal cells, STHdh striatal cells, and rat primary cortical neurons challenged with GLN. Our results indicated that GLN promotes learning and memory functions in mice and upregulates FGF21 expression in the hippocampus, cortex, and striatum, as well as in HT22 cells, STHdh cells, and cortical neurons. In animals receiving GLN together with an FGF21 receptor FGFR1 inhibitor (PD173074), the GLN-enhanced learning and memory functions and induction of FGF21 production in the hippocampus were significantly attenuated. While exploring the underlying molecular mechanisms, the potential involvement of NF-κB, Akt, p38, JNK, PKA, and PPARα in HT22 and NF-κB, Akt, p38, and PPARα in STHdh were noted; GLN was able to mediate the activation of p65, Akt, p38, and CREB in HT22 and p65, Akt, and p38 in STHdh cells. Our accumulated findings suggest that GLN may increase learning and memory functions by inducing FGF21 production in the brain. This induction appears to be mediated, at least in part, through GLN's activation of the NF-κB, Akt, p38, and PKA/CREB pathways.

Citing Articles

Causality of genetically determined glucosamine supplementation on cognition and sarcopenia: a Mendelian randomization study.

Kang Y, Tang Y, Kong W, Zhu T, Chen G Front Endocrinol (Lausanne). 2025; 15:1404308.

PMID: 39764251 PMC: 11700805. DOI: 10.3389/fendo.2024.1404308.

References
1.
Simon R, Marks V, Leeds A, Anderson J . A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals. Diabetes Metab Res Rev. 2011; 27(1):14-27. PMC: 3042150. DOI: 10.1002/dmrr.1150. View

2.
Jamialahmadi K, Arasteh O, Riahi M, Mehri S, Riahi-Zanjani B, Karimi G . Protective effects of glucosamine hydrochloride against free radical-induced erythrocytes damage. Environ Toxicol Pharmacol. 2014; 38(1):212-9. DOI: 10.1016/j.etap.2014.05.018. View

3.
Kang K, Xu P, Wang M, Chunyu J, Sun X, Ren G . FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress. Biomed Pharmacother. 2020; 129:110439. DOI: 10.1016/j.biopha.2020.110439. View

4.
Jamialahmadi K, Sadeghnia H, Mohammadi G, Kazemabad A, Hosseini M . Glucosamine alleviates scopolamine induced spatial learning and memory deficits in rats. Pathophysiology. 2013; 20(4):263-7. DOI: 10.1016/j.pathophys.2013.04.003. View

5.
Chen P, Tang H, Zhang Q, Xu L, Zhou W, Hu X . Basic Fibroblast Growth Factor (bFGF) Protects the Blood-Brain Barrier by Binding of FGFR1 and Activating the ERK Signaling Pathway After Intra-Abdominal Hypertension and Traumatic Brain Injury. Med Sci Monit. 2020; 26:e922009. PMC: 7029819. DOI: 10.12659/MSM.922009. View